finmarketnews.com
news-details
Health,Pot Stock,Watchlist

2 Healthcare & Biotech Stocks up over 22% past 10 days

⬆ 2 Healthcare & Biotech Stocks up over 22% past 10 days
Powered by HealthTechMovers.com


Below is a list of  2 Healthcare & Biotech Stocks up over 22% past 10 days and have been added to our watchlist.  These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.

One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com.

Longeveron, LGVN
Summary: Longeveron Inc. is a clinical stage biotechnology company. It engages in developing cellular therapies for chronic aging-related and life-threatening conditions. The company's investigational product includes LOMECEL-B(TM). Longeveron Inc. is based in MIAMI.
 
Ticker Company Sector Previous Close *Recent Price % Price Change Past 10 Days
LGVN Longeveron Healthcare & Biotech $12.32 $12.28 +38%
 
Here are 3rd party ratings for LGVN
  • TipRanks.com: Moderate Buy
  • TradingView.com: Buy
  • Yahoo! Finance: Bullish
  • Barchart.com: Strong buy
  • Zacks Rating: n/a
What’s the sentiment on the street?
Current ratings compiled by TipRanks.com
  • News Sentiment: Neutral
  • Blogger Consensus: Bullish
  • Media Buzz: Very Low
  • Insider Signal:
  • Investor Sentiment: Very Positive
  • Hedge Fund signal: No Signal

Click for Chart >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

AgeX Therapeutics, AGE
Summary: AgeX Therapeutics Inc. is involved in the development and commercialization of novel therapeutics targeting human aging. The company's proprietary technology consists of PureStem(R) and Tissue Regeneration(TM). Its product pipeline includes AGEX-VASC1, AGEX-BAT1, AGEX-iTR1547 and Renelon(TM). AgeX Therapeutics Inc. is based in Alameda, United States.
 
Ticker Company Sector Previous Close *Recent Price % Price Change Past 10 Days
AGE AgeX Therapeutics Healthcare & Biotech $1.00 $1 +22%
 
Here are 3rd party ratings for AGE
  • TipRanks.com: N/A
  • TradingView.com: Strong Buy
  • Yahoo! Finance: Bullish
  • Barchart.com: buy
  • Zacks Rating: n/a
What’s the sentiment on the street?
Current ratings compiled by TipRanks.com
  • News Sentiment:
  • Blogger Consensus:
  • Media Buzz:
  • Insider Signal:
  • Investor Sentiment: Very Negative
  • Hedge Fund signal: No Signal

Click for Chart >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------